Home › NDC Lookup › RxCUI directory › RxCUI 402000

Zolmitriptan 5 MG/ACTUAT Nasal Spray — RxCUI 402000

RxNorm drug concept · Semantic clinical drug
RxCUI 402000 Semantic clinical drug · SCD ● Current RxNorm concept 8 FDA products 8 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI402000
Official nameZolmitriptan 5 MG/ACTUAT Nasal Spray
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aszolmitriptan 5 MG/0.1 ML Nasal Spray
FDA products mapped8
Package NDCs mapped8
Reported Medicaid activity (SDUD)5,993 prescriptions · 30 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Zolmitriptan: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Zolmitriptan is designed to treat a migraine that's already started, not just dull the pain a little. It works on specific receptors in the brain to help narrow the widened blood v...
  • What exactly does zolmitriptan do — will it stop my migraine or just take the edge off?
  • Yes — if your migraine hasn't fully gone away after 2 hours, or if it comes back after initially getting better, you can take a second dose. You just need to wait at least 2 hours...
  • Can I take it again if my headache comes back a few hours later?
📖 Read our full Zolmitriptan guide →

🕸️ Concept Web — How Zolmitriptan 5 MG/ACTUAT Nasal Spray Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Zolmitriptan 5 MG/ACTUAT Nasal Spray RxCUI 402000

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Zolmitriptan 135775
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Zomig 153354
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Zolmitriptan Nasal Spray 402420
    • Zolmitriptan Inhalant Product 1156254
    • Zolmitriptan Nasal Product 1156255
    • Zolmitriptan Nasal Spray [Zomig] 402392
    • Zomig Inhalant Product 1188175
    • Zomig Nasal Product 1188176
    • Nasal Spray 126542
    • Inhalant Product 1151123
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Zolmitriptan 5 MG/ACTUAT SCDC · 402391
  • Zolmitriptan Nasal Spray SCDF · 402420
  • Zolmitriptan Inhalant Product SCDG · 1156254
  • Zolmitriptan Nasal Product SCDG · 1156255

Brand-Name Concepts

  • Zolmitriptan 5 MG/ACTUAT Nasal Spray [Zomig] SBD · 402169
  • Zolmitriptan 5 MG/ACTUAT [Zomig] SBDC · 576112
  • Zolmitriptan Nasal Spray [Zomig] SBDF · 402392
  • Zomig Inhalant Product SBDG · 1188175
  • Zomig Nasal Product SBDG · 1188176
  • Zomig BN · 153354

📦 FDA Products & Package NDCs

8 products · 8 package NDCs
8 package NDCs map to RxCUI 402000 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
45802-0711-91 6 BOTTLE, SPRAY in 1 CARTON (45802-711-91) / 1 SPRAY in 1 B... zolmitriptan Padagis Israel Pharmaceuticals Ltd 2021-11-16
63629-9575-01 6 BOTTLE, SPRAY in 1 CARTON (63629-9575-1) / 1 SPRAY in 1 B... zolmitriptan Bryant Ranch Prepack 2022-12-21
64896-0083-12 6 BOTTLE, SPRAY in 1 CARTON (64896-083-12) / 1 SPRAY, METER... ZOMIG Amneal Pharmaceuticals LLC 2024-07-15
64896-0084-12 6 BOTTLE, SPRAY in 1 CARTON (64896-084-12) / 1 SPRAY, METER... ZOMIG Amneal Pharmaceuticals LLC 2024-07-15
69238-2351-06 6 BOTTLE, SPRAY in 1 CARTON (69238-2351-6) / 1 SPRAY, METER... Zolmitriptan Amneal Pharmaceuticals NY LLC 2024-07-15
69238-2352-06 6 BOTTLE, SPRAY in 1 CARTON (69238-2352-6) / 1 SPRAY, METER... Zolmitriptan Amneal Pharmaceuticals NY LLC 2024-07-15
71335-2947-01 6 BOTTLE, SPRAY in 1 CARTON (71335-2947-1) / 1 SPRAY in 1 B... zolmitriptan Bryant Ranch Prepack 2025-10-28
72162-1425-02 6 BOTTLE, SPRAY in 1 CARTON (72162-1425-2) / 1 SPRAY in 1 B... zolmitriptan Bryant Ranch Prepack 2025-04-03
Observed labelers: Bryant Ranch Prepack (3) · Amneal Pharmaceuticals LLC (2) · Amneal Pharmaceuticals NY LLC (2) · Padagis Israel Pharmaceuticals Ltd (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.